Previous post Next post

US trade deal forces reckoning for Swiss pharma powerhouse

Swiss pharmaceutical companies are planning massive investments in research and manufacturing in the United States as part of a deal to secure lower tariffs. But this isn’t the only force fuelling anxiety about the future of Switzerland’s pharma dominance. The Swiss pharmaceutical sector had reason to celebrate on Friday when the government announced a trade deal with the US that brings tariffs from 39% to 15%. The deal also excludes medicine from tariffs for the time being. The tariff rate on pharmaceutical goods will also be capped at 15% if Trump seeks to impose levies on additional sectors. This is much lower than the 200% on branded drugs US President Trump had threatened over the summer. Novartis, Roche plan US moves The tariff deal, which isn’t finalised yet, came about thanks in large part to huge investment pledges by Swiss pharmaceutical giants Roche and Novartis. These amount to a combined $73 billion (CHF58 billion) over the next five years with the aim to produce all ... Full story here Are you the author?
About Swissinfo
Swissinfo
SWI swissinfo.ch – the international service of the Swiss Broadcasting Corporation (SBC). Since 1999, swissinfo.ch has fulfilled the federal government’s mandate to distribute information about Switzerland internationally, supplementing the online offerings of the radio and television stations of the SBC. Today, the international service is directed above all at an international audience interested in Switzerland, as well as at Swiss citizens living abroad.
Previous post See more for 3.) Swissinfo Business and Economy Next post
Tags: ,

Permanent link to this article: https://snbchf.com/2025/11/trade-deal-forces-reckoning-swiss-pharma-powerhouse/

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>

This site uses Akismet to reduce spam. Learn how your comment data is processed.